相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overexpressed CXCR4 and CCR7 on the surface of NK92 cell have improved migration and anti-tumor activity in human colon tumor model
Lili Yang et al.
ANTI-CANCER DRUGS (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts
Yu Yang Ng et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
Feng Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway
Costanza Maria Cristiani et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology
Xuanmao Jiao et al.
CANCER RESEARCH (2019)
Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
Ziqing Chen et al.
CANCERS (2019)
Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
Piotr Wojdasiewicz et al.
MEDIATORS OF INFLAMMATION (2019)
The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas
Feifei Ren et al.
IMMUNOLOGY AND CELL BIOLOGY (2019)
CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation
Min Yao et al.
MOLECULAR CANCER RESEARCH (2019)
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
Ryuma Tokunaga et al.
CANCER TREATMENT REVIEWS (2018)
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
Jhajaira M. Araujo et al.
SCIENTIFIC REPORTS (2018)
LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the JAK/STAT pathway
Peng Wang et al.
APOPTOSIS (2018)
CXCR3-deficient natural killer cells fail to migrate to B16F10 melanoma cells
Juyoung Kim et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model
Kun-Yu Teng et al.
MOLECULAR CANCER THERAPEUTICS (2017)
E6130, a Novel CX3C Chemokine Receptor 1 (CX3CR1) Modulator, Attenuates Mucosal Inflammation and Reduces CX3CR1+ Leukocyte Trafficking in Mice with Colitis
Hisashi Wakita et al.
MOLECULAR PHARMACOLOGY (2017)
Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner
Takouhie Mgrditchian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
TGF-β1 Downregulates the Expression of CX3CR1 by Inducing miR-27a-5p in Primary Human NK Cells
Stefano Regis et al.
FRONTIERS IN IMMUNOLOGY (2017)
Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice
Takuya Yano et al.
PLOS ONE (2017)
Immunomodulatory Magnetic Microspheres for Augmenting Tumor-Specific Infiltration of Natural Killer (NK) Cells
Wooram Park et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Targeting the tumor microenvironment to improve natural killer cell-based immunotherapies: On being in the right place at the right time, with resilience
Shannon Murray et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
J. M. Pitt et al.
ANNALS OF ONCOLOGY (2016)
CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation
Laura Hertwig et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways
Kelly Hudspeth et al.
JOURNAL OF AUTOIMMUNITY (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
HCMV vCXCL1 Binds Several Chemokine Receptors and Preferentially Attracts Neutrophils over NK Cells by Interacting with CXCR2
Rachel Yamin et al.
CELL REPORTS (2016)
Efficient mRNA-Based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7 Augments Rituximab-Induced ADCC against Lymphoma and Targets NK Cell Migration toward the Lymph Node-Associated Chemokine CCL19
Mattias Carlsten et al.
FRONTIERS IN IMMUNOLOGY (2016)
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor
Silvia Pesce et al.
FRONTIERS IN IMMUNOLOGY (2016)
Hanna J, Mussaffi H, Steuer G, et al. Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency. Blood. 2005;106(10):3465-3473.
BLOOD (2015)
Chemokine-guided cell positioning in the lymph node orchestrates the generation of adaptive immune responses
Jeffrey Lian et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasis
Marko Roblek et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
Nadja Müller et al.
JOURNAL OF IMMUNOTHERAPY (2015)
PTEN regulates natural killer cell trafficking in vivo
Jeffrey W. Leong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The Chemokine System in Innate Immunity
Caroline L. Sokol et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration
Timothy J. Zumwalt et al.
ONCOTARGET (2015)
Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma
Jinyan Liu et al.
ONCOTARGET (2015)
CCR2 inhibition sequesters multiple subsets of leukocytes in the bone marrow
Naoki Fujimura et al.
SCIENTIFIC REPORTS (2015)
Immune signature of tumor infiltrating immune cells in renal cancer
Katharina Geissler et al.
ONCOIMMUNOLOGY (2015)
Promoting NK cell trafficking to improve therapeutic effect of NK cell therapy on osteosarcoma
Yuanzheng Yang et al.
Journal for ImmunoTherapy of Cancer (2015)
CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
Erik Wennerberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
Paolo Carrega et al.
JOURNAL OF IMMUNOLOGY (2014)
A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis
Antonino Bruno et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
IFN-gamma induces aberrant CD49b(+) NK cell recruitment through regulating CX3CL1: a novel mechanism by which IFN-gamma provokes pregnancy failure
Z-Y Li et al.
CELL DEATH & DISEASE (2014)
Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients
Talib Hassan Ali et al.
NATURE COMMUNICATIONS (2014)
Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
Sylvie Rusakiewicz et al.
CANCER RESEARCH (2013)
Human memory-like NK cells migrating to tuberculous pleural fluid via IP-10/CXCR3 and SDF-1/CXCR4 axis produce IFN-γ in response to Bacille Calmette Guerin
Xiaoying Fu et al.
CLINICAL IMMUNOLOGY (2013)
Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients
Yamila S. Rocca et al.
INNATE IMMUNITY (2013)
CX3CR1 Regulates the Maintenance of KLRG1+ NK Cells into the Bone Marrow by Promoting Their Entry into Circulation
Andrea Ponzetta et al.
JOURNAL OF IMMUNOLOGY (2013)
Neuroblastoma-Derived TGF-β1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells
Roberta Castriconi et al.
JOURNAL OF IMMUNOLOGY (2013)
A Novel CXCL10-Based GPI-Anchored Fusion Protein as Adjuvant in NK-Based Tumor Therapy
Niklas Muenchmeier et al.
PLOS ONE (2013)
Membrane-anchored chemokine fusion proteins A novel class of adjuvants for immunotherapy
Peter J. Nelson et al.
ONCOIMMUNOLOGY (2013)
Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7
Srinivas S. Somanchi et al.
BLOOD (2012)
Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging
Judith Eckl et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma
Min Ho Park et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
CCR2 Defines a Distinct Population of NK Cells and Mediates Their Migration during Influenza Virus Infection in Mice
Mary J. G. van Helden et al.
PLOS ONE (2012)
CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow
Giuseppe Sciume et al.
BLOOD (2011)
Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking
Katia Mayol et al.
BLOOD (2011)
Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and function
Ardiana Moustaki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Ccr5 deficiency regulates the proliferation and trafficking of natural killer cells under physiological conditions
Ido D. Weiss et al.
CYTOKINE (2011)
Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism
Benjamin Bondue et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The emerging role of CXCL10 in cancer (Review)
Mingli Liu et al.
ONCOLOGY LETTERS (2011)
Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice
Noah Saederup et al.
PLOS ONE (2010)
CCL5-Mediated Endogenous Antitumor Immunity Elicited by Adoptively Transferred Lymphocytes and Dendritic Cell Depletion
Yolanda Nesbeth et al.
CANCER RESEARCH (2009)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56BrightCD16- cells and display an impaired capability to kill tumor cells
Paolo Carrega et al.
CANCER (2008)
Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands
Marco Wendel et al.
CANCER RESEARCH (2008)
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
S. Arai et al.
CYTOTHERAPY (2008)
Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B
Ilaria Petrai et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis
Carolina Otero et al.
JOURNAL OF CELL SCIENCE (2008)
Chemokine production and chemokine receptor expression by human glioma cells: Role of CXCL10 in tumour cell proliferation
Seema V. Maru et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes
Che Liu et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
CCR7 and its ligands:: balancing immunity and tolerance
Reinhold Foerster et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor
Thierry Walzer et al.
NATURE IMMUNOLOGY (2007)
Defective antitumor responses in CX3CR1-deficient mice
Yen-Rei A. Yu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes
K. Kawada et al.
ONCOGENE (2007)
Evidence for NK cell subsets based on chemokine receptor expression
Robert D. Berahovich et al.
JOURNAL OF IMMUNOLOGY (2006)
Intercellular exchanges of membrane patches (trogocytosis) highlight the next level of immune plasticity
Julien Caumartin et al.
TRANSPLANT IMMUNOLOGY (2006)
Opposite fate of endocytosed CCR7 and its ligands: Recycling versus degradation
Carolina Otero et al.
JOURNAL OF IMMUNOLOGY (2006)
Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer
Tonya C. Walser et al.
CANCER RESEARCH (2006)
CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection
Imtiaz A. Khan et al.
PLOS PATHOGENS (2006)
The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system
Deren Huang et al.
FASEB JOURNAL (2006)
CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH cytokine production
P Romagnani et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection
JW Tyner et al.
NATURE MEDICINE (2005)
Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients
C Infante-Duarte et al.
FASEB JOURNAL (2005)
Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis
Y Terashima et al.
NATURE IMMUNOLOGY (2005)
Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury
R Bertini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
IL-15 alters expression and function of the chemokine receptor CX3CR1 inhuman NK cells
JM Sechler et al.
CELLULAR IMMUNOLOGY (2004)
Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes
K Kawada et al.
CANCER RESEARCH (2004)
IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1
J Barlic et al.
BLOOD (2003)
The chemokine CX3CL1 regulates NK cell activity in vivo
LA Robinson et al.
CELLULAR IMMUNOLOGY (2003)
Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice
K Beider et al.
BLOOD (2003)
What is trogocytosis and what is its purpose?
E Joly et al.
NATURE IMMUNOLOGY (2003)
Chemokines and chemokine receptors in leukocyte trafficking
TS Olson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2002)
IL-2 and IL-12 alter NK cell responsiveness to IFN-γ-inducible protein 10 by down-regulating CXCR3 expression
DL Hodge et al.
JOURNAL OF IMMUNOLOGY (2002)
Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression
M Nishimura et al.
JOURNAL OF IMMUNOLOGY (2002)
Expression and regulation of chemokine receptors in human natural killer cells
M Inngjerdingen et al.
BLOOD (2001)
分享论文
